NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and ...
Intravenous thrombolysis (IVT) administered within 4.5 hours was linked to significantly lower risk for neurological deterioration in acute pontine infarction than other antithrombotic therapies, new ...
Helius Medical Technologies announces PoNS System's sale to VA Healthcare, advancing treatment for veterans with gait deficits from MS. Helius Medical Technologies, Inc. announced the first sale of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results